The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agents.

Gravett, Andrew M; Dennis, Jayne L; Dalgleish, Angus G; Copier, John; Liu, Wai M

Gravett, Andrew M; Dennis, Jayne L; Dalgleish, Angus G; Copier, John; Liu, Wai M.

Afiliación

Gravett AM; Institute for Infection and Immunity, Department of Oncology, St. George's, University of London, London SW17 0RE, UK.
Dennis JL; Institute for Infection and Immunity, Department of Oncology, St. George's, University of London, London SW17 0RE, UK.
Dalgleish AG; Institute for Infection and Immunity, Department of Oncology, St. George's, University of London, London SW17 0RE, UK.
Copier J; Institute for Infection and Immunity, Department of Oncology, St. George's, University of London, London SW17 0RE, UK.
Liu WM; Institute for Infection and Immunity, Department of Oncology, St. George's, University of London, London SW17 0RE, UK.

Oncol Lett ; 20(6): 321, 2020 Dec.

Article en En | MEDLINE | ID: mdl-33093925

Palabras clave

cancer; chemotherapeutics; combinations; microarray

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google